The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Adagio Medical and ARYA IV Partner to Create a Publicly Traded Company Focused on Innovative Technologies for Treatment of Cardiac Arrhythmias
Jul 31, 2024•almost 2 years ago
Contract Type
partnership
Laguna HillsHealthcareHealth Care
Description
Adagio Medical announced the completion of its business combination with ARYA IV, resulting in the creation of a publicly traded company focused on innovative technologies for the treatment of cardiac arrhythmias. The business combination was approved by the shareholders and the combined company raised approximately $84.2 million in financing.
Company Information
Company
Adagio Medical
Location
26051 MERIT CIRCLE
Laguna Hills, California, United States
About
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias utilizing its novel, proprietary, catheter-based Ultra-Low Temperature Cryoablation (ULTC) technology. ULTC is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The Company is currently focused on the treatment of ventricular tachycardia (VT) with its purpose-built vCLASTM Cryoablation System which is CE Marked and is currently under evaluation in the Company’s FULCRUM-VT U.S. IDE Pivotal Study.
Laguna HillsHealthcareHealth Care